Akt and 14-3-3 Control a PACS-2 Homeostatic Switch that Integrates Membrane Traffic with TRAIL-Induced Apoptosis

Joseph Aslan, Huihong You, Danielle M. Williamson, Jessica Endig, Robert T. Youker, Laurel Thomas, Hongjun Shu, Yuhong Du, Robert L. Milewski, Matthew H. Brush, Anthony Possemato, Kam Sprott, Haian Fu, Kenneth D. Greis, Douglas N. Runckel, Arndt Vogel, Gary Thomas

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

TRAIL selectively kills diseased cells in vivo, spurring interest in this death ligand as a potential therapeutic. However, many cancer cells are resistant to TRAIL, suggesting the mechanism mediating TRAIL-induced apoptosis is complex. Here we identify PACS-2 as an essential TRAIL effector, required for killing tumor cells in vitro and virally infected hepatocytes in vivo. PACS-2 is phosphorylated at Ser437 in vivo, and pharmacologic and genetic studies demonstrate Akt is an in vivo Ser437 kinase. Akt cooperates with 14-3-3 to regulate the homeostatic and apoptotic properties of PACS-2 that mediate TRAIL action. Phosphorylated Ser437 binds 14-3-3 with high affinity, which represses PACS-2 apoptotic activity and is required for PACS-2 to mediate trafficking of membrane cargo. TRAIL triggers dephosphorylation of Ser437, reprogramming PACS-2 to promote apoptosis. Together, these studies identify the phosphorylation state of PACS-2 Ser437 as a molecular switch that integrates cellular homeostasis with TRAIL-induced apoptosis.

Original languageEnglish (US)
Pages (from-to)497-509
Number of pages13
JournalMolecular Cell
Volume34
Issue number4
DOIs
StatePublished - May 14 2009

Fingerprint

Apoptosis
Membranes
Hepatocytes
Neoplasms
Homeostasis
Phosphotransferases
Phosphorylation
Ligands
Therapeutics

Keywords

  • CELLBIO
  • CELLCYCLE
  • PROTEINS

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Akt and 14-3-3 Control a PACS-2 Homeostatic Switch that Integrates Membrane Traffic with TRAIL-Induced Apoptosis. / Aslan, Joseph; You, Huihong; Williamson, Danielle M.; Endig, Jessica; Youker, Robert T.; Thomas, Laurel; Shu, Hongjun; Du, Yuhong; Milewski, Robert L.; Brush, Matthew H.; Possemato, Anthony; Sprott, Kam; Fu, Haian; Greis, Kenneth D.; Runckel, Douglas N.; Vogel, Arndt; Thomas, Gary.

In: Molecular Cell, Vol. 34, No. 4, 14.05.2009, p. 497-509.

Research output: Contribution to journalArticle

Aslan, J, You, H, Williamson, DM, Endig, J, Youker, RT, Thomas, L, Shu, H, Du, Y, Milewski, RL, Brush, MH, Possemato, A, Sprott, K, Fu, H, Greis, KD, Runckel, DN, Vogel, A & Thomas, G 2009, 'Akt and 14-3-3 Control a PACS-2 Homeostatic Switch that Integrates Membrane Traffic with TRAIL-Induced Apoptosis', Molecular Cell, vol. 34, no. 4, pp. 497-509. https://doi.org/10.1016/j.molcel.2009.04.011
Aslan, Joseph ; You, Huihong ; Williamson, Danielle M. ; Endig, Jessica ; Youker, Robert T. ; Thomas, Laurel ; Shu, Hongjun ; Du, Yuhong ; Milewski, Robert L. ; Brush, Matthew H. ; Possemato, Anthony ; Sprott, Kam ; Fu, Haian ; Greis, Kenneth D. ; Runckel, Douglas N. ; Vogel, Arndt ; Thomas, Gary. / Akt and 14-3-3 Control a PACS-2 Homeostatic Switch that Integrates Membrane Traffic with TRAIL-Induced Apoptosis. In: Molecular Cell. 2009 ; Vol. 34, No. 4. pp. 497-509.
@article{d5dbe845ed75499888f3a64945068133,
title = "Akt and 14-3-3 Control a PACS-2 Homeostatic Switch that Integrates Membrane Traffic with TRAIL-Induced Apoptosis",
abstract = "TRAIL selectively kills diseased cells in vivo, spurring interest in this death ligand as a potential therapeutic. However, many cancer cells are resistant to TRAIL, suggesting the mechanism mediating TRAIL-induced apoptosis is complex. Here we identify PACS-2 as an essential TRAIL effector, required for killing tumor cells in vitro and virally infected hepatocytes in vivo. PACS-2 is phosphorylated at Ser437 in vivo, and pharmacologic and genetic studies demonstrate Akt is an in vivo Ser437 kinase. Akt cooperates with 14-3-3 to regulate the homeostatic and apoptotic properties of PACS-2 that mediate TRAIL action. Phosphorylated Ser437 binds 14-3-3 with high affinity, which represses PACS-2 apoptotic activity and is required for PACS-2 to mediate trafficking of membrane cargo. TRAIL triggers dephosphorylation of Ser437, reprogramming PACS-2 to promote apoptosis. Together, these studies identify the phosphorylation state of PACS-2 Ser437 as a molecular switch that integrates cellular homeostasis with TRAIL-induced apoptosis.",
keywords = "CELLBIO, CELLCYCLE, PROTEINS",
author = "Joseph Aslan and Huihong You and Williamson, {Danielle M.} and Jessica Endig and Youker, {Robert T.} and Laurel Thomas and Hongjun Shu and Yuhong Du and Milewski, {Robert L.} and Brush, {Matthew H.} and Anthony Possemato and Kam Sprott and Haian Fu and Greis, {Kenneth D.} and Runckel, {Douglas N.} and Arndt Vogel and Gary Thomas",
year = "2009",
month = "5",
day = "14",
doi = "10.1016/j.molcel.2009.04.011",
language = "English (US)",
volume = "34",
pages = "497--509",
journal = "Molecular Cell",
issn = "1097-2765",
publisher = "Cell Press",
number = "4",

}

TY - JOUR

T1 - Akt and 14-3-3 Control a PACS-2 Homeostatic Switch that Integrates Membrane Traffic with TRAIL-Induced Apoptosis

AU - Aslan, Joseph

AU - You, Huihong

AU - Williamson, Danielle M.

AU - Endig, Jessica

AU - Youker, Robert T.

AU - Thomas, Laurel

AU - Shu, Hongjun

AU - Du, Yuhong

AU - Milewski, Robert L.

AU - Brush, Matthew H.

AU - Possemato, Anthony

AU - Sprott, Kam

AU - Fu, Haian

AU - Greis, Kenneth D.

AU - Runckel, Douglas N.

AU - Vogel, Arndt

AU - Thomas, Gary

PY - 2009/5/14

Y1 - 2009/5/14

N2 - TRAIL selectively kills diseased cells in vivo, spurring interest in this death ligand as a potential therapeutic. However, many cancer cells are resistant to TRAIL, suggesting the mechanism mediating TRAIL-induced apoptosis is complex. Here we identify PACS-2 as an essential TRAIL effector, required for killing tumor cells in vitro and virally infected hepatocytes in vivo. PACS-2 is phosphorylated at Ser437 in vivo, and pharmacologic and genetic studies demonstrate Akt is an in vivo Ser437 kinase. Akt cooperates with 14-3-3 to regulate the homeostatic and apoptotic properties of PACS-2 that mediate TRAIL action. Phosphorylated Ser437 binds 14-3-3 with high affinity, which represses PACS-2 apoptotic activity and is required for PACS-2 to mediate trafficking of membrane cargo. TRAIL triggers dephosphorylation of Ser437, reprogramming PACS-2 to promote apoptosis. Together, these studies identify the phosphorylation state of PACS-2 Ser437 as a molecular switch that integrates cellular homeostasis with TRAIL-induced apoptosis.

AB - TRAIL selectively kills diseased cells in vivo, spurring interest in this death ligand as a potential therapeutic. However, many cancer cells are resistant to TRAIL, suggesting the mechanism mediating TRAIL-induced apoptosis is complex. Here we identify PACS-2 as an essential TRAIL effector, required for killing tumor cells in vitro and virally infected hepatocytes in vivo. PACS-2 is phosphorylated at Ser437 in vivo, and pharmacologic and genetic studies demonstrate Akt is an in vivo Ser437 kinase. Akt cooperates with 14-3-3 to regulate the homeostatic and apoptotic properties of PACS-2 that mediate TRAIL action. Phosphorylated Ser437 binds 14-3-3 with high affinity, which represses PACS-2 apoptotic activity and is required for PACS-2 to mediate trafficking of membrane cargo. TRAIL triggers dephosphorylation of Ser437, reprogramming PACS-2 to promote apoptosis. Together, these studies identify the phosphorylation state of PACS-2 Ser437 as a molecular switch that integrates cellular homeostasis with TRAIL-induced apoptosis.

KW - CELLBIO

KW - CELLCYCLE

KW - PROTEINS

UR - http://www.scopus.com/inward/record.url?scp=65849216826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65849216826&partnerID=8YFLogxK

U2 - 10.1016/j.molcel.2009.04.011

DO - 10.1016/j.molcel.2009.04.011

M3 - Article

C2 - 19481529

AN - SCOPUS:65849216826

VL - 34

SP - 497

EP - 509

JO - Molecular Cell

JF - Molecular Cell

SN - 1097-2765

IS - 4

ER -